Illinois Compiled Statutes 410 ILCS 649/10 – Definitions
Current as of: 2024 | Check for updates
|
Other versions
For the purposes of this Act:
“Accident and health insurer” has the meaning given to that term in § 126.2 of the Illinois Insurance Code.
“Eligible patient” means a person who:
(1) has a terminal illness;
(2) has considered all other treatment options
“Accident and health insurer” has the meaning given to that term in § 126.2 of the Illinois Insurance Code.
Terms Used In Illinois Compiled Statutes 410 ILCS 649/10
- Guardian: A person legally empowered and charged with the duty of taking care of and managing the property of another person who because of age, intellect, or health, is incapable of managing his (her) own affairs.
- Trial: A hearing that takes place when the defendant pleads "not guilty" and witnesses are required to come to court to give evidence.
- United States: may be construed to include the said district and territories. See Illinois Compiled Statutes 5 ILCS 70/1.14
“Eligible patient” means a person who:
(1) has a terminal illness;
(2) has considered all other treatment options
|
approved by the United States Food and Drug Administration;
|
(3) has received a prescription or recommendation
|
from his or her physician for an investigational drug, biological product, or device;
|
(4) has given his or her informed consent in writing
|
for the use of the investigational drug, biological product, or device or, if he or she is a minor or lacks the mental capacity to provide informed consent, a parent or legal guardian has given informed consent on his or her behalf; and
|
(5) has documentation from his or her physician
|
indicating that he or she has met the requirements of this Act.
|
“Investigational drug, biological product, or device” means a drug, biological product, or device that has successfully completed Phase I of a clinical trial, but has not been approved for general use by the United States Food and Drug Administration.
“Phase I of a clinical trial” means the stage of a clinical trial where an investigational drug, biological product, or device has been tested in a small group for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
“Terminal illness” means a disease that, without life-sustaining measures, can reasonably be expected to result in death in 24 months or less.
“Phase I of a clinical trial” means the stage of a clinical trial where an investigational drug, biological product, or device has been tested in a small group for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
“Terminal illness” means a disease that, without life-sustaining measures, can reasonably be expected to result in death in 24 months or less.